pyrazolanthrone has been researched along with Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, ZN; Cui, J; Fan, XY; Jiang, JL; Li, YM; Li, ZC; Liu, ZY; Tang, J; Wang, JC; Yang, HJ; Yu, JM; Zheng, M | 1 |
Bennett, BL; Kitazaki, S; Mitsuyama, K; Sata, M; Satoh, Y; Suzuki, A; Takeda, T; Tomiyasu, N; Toyonaga, A; Tsuruta, O | 1 |
2 other study(ies) available for pyrazolanthrone and Colitis
Article | Year |
---|---|
RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
Topics: Adaptive Immunity; Animals; Anthracenes; Apoptosis; Carcinogenesis; Cell Proliferation; Chemokine CXCL1; Colitis; Colon; Colonic Neoplasms; Colorectal Neoplasms; Epithelial Cells; Gene Expression; Gene Knockout Techniques; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Necroptosis; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; T-Lymphocytes | 2019 |
Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease.
Topics: Animals; Anthracenes; Case-Control Studies; Colitis; Cytokines; Disease Models, Animal; Female; Gastric Mucosa; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Monocytes; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors | 2006 |